Azalea Therapeutics Presents New Preclinical Data Demonstrating Robust In Vivo Generation of TRAC-CAR T Cells Using Enveloped Delivery Vehicles (EDVs)

In vivo platform enables efficient, site-specific CAR gene insertion under control of an endogenous T cell promoter, producing functional CAR T cells inside the body Single dose administration in ...

Men spend billions on social media wellness trends - despite little proof they work

A shocking study has found more and more men are turning to unproven social media wellness trends - with those over 35 ...
Pharmaceutical Technology

The resurgence of mesenchymal stem cell therapies

Mesenchymal stem cells have been explored across a wide range of diseases due to their potential to reduce inflammation and ...
PharmiWeb

Monoclonal Antibody Therapeutics Market Growth Analysis, Size, Share, Analysis, COVID 19 Analysis, Opportunities and Challenges with Focus on Top Players, Forecast to 2030

Global Monoclonal Antibody Therapeutics Market OverviewThe global monoclonal antibody therapeutics market is poised for substantial expansion, projected to grow at a CAGR of approximately 12% over the ...
Le Lézard

FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER

Amgen announced today that the U.S. Food and Drug Administration (FDA) has granted full approval to IMDELLTRA® (tarlatamab-dlle) for the treatment of adult patients with extensive stage small cell ...
The Malaysian Reserve

Cellipont Bioservices and Ronawk Partner to Advance Scalable Expansion of High-Quality Mesenchymal Stem Cells and Biologics

THE WOODLANDS, Texas and OVERLAND PARK, Kan., Nov. 19, 2025 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy ...
MyChesCo on MSN

Century Therapeutics Debuts Immune-Evasive Cell Therapy Aiming to Transform Type 1 Diabetes

Century Therapeutics, Inc. (NASDAQ: IPSC) has unveiled its first program targeting Type 1 diabetes, introducing an engineered ...